XOMA Co. (NASDAQ:XOMAP – Get Free Report) saw a significant growth in short interest in the month of May. As of May 15th, there was short interest totaling 308 shares, a growth of 152.5% from the April 30th total of 122 shares. Based on an average daily volume of 771 shares, the days-to-cover ratio is currently 0.4 days.
XOMA Price Performance
Shares of NASDAQ:XOMAP opened at $25.45 on Monday. The company’s 50 day simple moving average is $25.84 and its 200 day simple moving average is $26.18. XOMA has a 1 year low of $25.14 and a 1 year high of $30.00.
XOMA Company Profile
XOMA Corporation (NASDAQ: XOMAP) is a clinical-stage biopharmaceutical company focused on the discovery and development of therapeutic antibodies for autoimmune and inflammatory diseases. The company leverages proprietary antibody-generation technologies—including ribosome display and phage display—to identify and optimize human monoclonal antibodies with high specificity and favorable pharmacological profiles.
Its lead clinical program is an interleukin-1 beta modulator being evaluated in patients with rare and severe inflammatory conditions.
Recommended Stories
- Five stocks we like better than XOMA
- Alphabet Bets on Hardware With Googlebook and AI Glasses
- Burlington Beat Earnings Estimates, But Not Investor Expectations
- Palantir Stock Faces Technical Pressure Despite Strong AI Growth
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
